June 24, 2026 02:35 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
No Hindi, no NEET: Vijay reignites Tamil Nadu's biggest political flashpoints | Messi creates World Cup history with record-breaking double; Mbappe equals Klose's mark hours later | Tech giant Oracle slashes 21,000 jobs while betting big on AI | 'Italy and I never beg': Meloni fires back at Trump over G7 photo claim | No more 'brother': Stalin's formal birthday greeting to Rahul reflects deepening rift | TMC seeks disqualification of 20 rebel MPs, Abhishek says 'membership should go' | Nara Lokesh pitches Andhra Pradesh as investment hub during Kolkata visit, sets $2.4 trillion economy goal | 'Least restrictive option': Setback for Telegram as Delhi HC backs Centre's ban ahead of NEET-UG re-test | Fortuner torched, BJP leaders burnt alive: Sand mining feud ends in triple murder in Chhattisgarh | 'If Modi is the leader and India is attacked, we'll be there': Trump's strong assurance at G7

Indian market remains subdued on Tuesday

| | Oct 31, 2017, at 09:45 pm

Mumbai, Oct 31 (IBNS): The Indian market closed lower on Tuesday, with BSE Sensex down 36.11 points at 33230.05,  and NSE Nifty down by 24.50 points at 10339.20.

On Tuesday, Dr. Reddy’s Laboratories Ltd  announced its consolidated financial results for the second quarter and half year ended September 30, 2017

The company reported consolidated profit for July-September quarter at Rs 284.9 crore, down 3.4 percent compared with Rs 295 crore reported in the same period a year ago.

Profit was slightly better than analyst estimates due to improvement in operational performance, the company said.

Revenue during the quarter fell 1.1 percent year-on-year to Rs 3,546 crore which dented by US business; but increased 7 percent sequentially.

"Healthy performance in India, emerging markets, Europe and PSAI businesses, as well as continued focus on cost control, have contributed to sequential growth in topline as well as bottomline, with an EBITDA increase of 105 percent over previous quarter," GV Prasad, CEO and co-chairman said.

He said, "Looking ahead, we expect to see results from products launched in the U.S. during the first half of this fiscal. We will continue to focus on the launching of new products, as well as on improving operational efficiency and quality management systems across the company.”

With Indian market regulator SEBI making it mandatory to link Aadhaar with all demat accounts, foreign portfolio investors have asked for clarification if the the rule also applies to them, according to media reports.

According to media reports, the August mandate, which asked the stock exchanges to freeze demat accounts of traders failing to provide Aadhaar details by December 31, was thought to be meant for domestic investors.

But it was not clear if overseas investors were also bound by the circular.

Top gainers on Tuesday included Axis Bank, ONGC, BHEL, HCL Tech, Bharti Airtel, BPCL and Hero Motocorp while UPL, Vedanta, Infosys, M&M, Gail, Tata Steel, SBI and Tata Motors declined.

 

Image: Wikimedia Commons

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm